Thrombolysis and Angioplasty in Acute Myocardial Infarction Study Group (TAMI-2 Trials). Coronary thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction (Circulation, 1988)